HelloBetter is a company in the field of digital therapeutics (DTx) for mental health and a pioneer in digital mental health research. It has the strongest evidence base globally, with a total of 33 randomized controlled trials published in peer-reviewed journals. In Germany, six of their therapy programmes are part of the standard of care and as such available to 70+ million people for free as prescription digital therapeutics or DiGA. Here are details of HelloBetter’s latest funding round :
David Ebert, Hanne Horvath, Elena Heber, Hannes Klöpper, Philip Ihde, Saman Hashemian, Amit Gupta, Pierre Cantegril
💸 Funding & Investors
- Investment (September 2023) : €5 million (as a second closing to its A2 round announced in May)
- Investors : HSBC Asset Management
🎯 Funding purpose
Scale up of its evidence-based mental health care products.
🌐 Country HQ